Delivery Order SPE2DB20D3103-SPE2DB26FL5E7
- Not listed
- The Defense Logistics Agency awarded a $2,754.00 delivery order to AmerisourceBergen Drug Corp for the supply of Mitomycin 20 mg vials under a firm fixed-price contract with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,956,675 units of the pharmaceutical product Mitomycin 20 mg vials. The $1,100.72 contract has a performance period through March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,832.60 to AmerisourceBergen Drug Corp for the supply of Micafungin 100 mg vials. This competitively awarded, firm fixed-price delivery order was executed on November 5, 2025, with an ultimate completion date of November 6, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This award represents a child contract action under the company's larger...
- The Defense Logistics Agency awarded a $2,847.08 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,550.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dactinomycin 500 microgram vials, with an ultimate completion date of September 18, 2025. This non-set-aside delivery order represents a competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for military and veteran...
- The Defense Logistics Agency awarded a $4,296.65 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mycophenolate 200 mg/ml suspension in a 160 ml quantity, with completion targeted for July 28, 2025. This firm fixed price contract represents a non-competitive set-aside award to the pharmaceutical distributor's corporate office, with performance to be executed in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery order...
- This delivery order, valued at $14,528.80 and awarded September 3, 2025, represents a competitive procurement by the Defense Logistics Agency (DLA) for MENQUADFI vials (0.5mL) from AmerisourceBergen Drug Corp, the primary pharmaceutical distributor for federal military and healthcare systems. The award is non-set-aside and utilizes firm fixed-price pricing, with completion scheduled for September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of...
- The Defense Logistics Agency awarded a $3,497.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Miostat Vial 1.5ML, a pharmaceutical product used primarily in ophthalmic procedures. This non-set-aside delivery order is scheduled for completion by October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,004.85 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its broader contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $40,038.61 to AmerisourceBergen Drug Corp on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL5E7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,146.40 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Mitomycin 5 mg vials. This is a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor, demonstrating extensive capability in supplying a broad range of pharmaceutical products and medical supplies to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio with DLA includes specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Mitomycin, an antitumor antibiotic commonly used in oncology, aligns with AmerisourceBergen's established role as a premier supplier of specialized pharmaceutical commodities supporting military medical readiness and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/6/25 |